Back to the list
Congress: ECR25
Poster Number: C-12858
Type: Poster: EPOS Radiologist (educational)
Authorblock: E. Akçiçek, A. E. Aldur, R. Göçmen; Ankara/TR
Disclosures:
Esra Akçiçek: Nothing to disclose
Ali Enes Aldur: Nothing to disclose
Rahşan Göçmen: Nothing to disclose
Keywords: Neuroradiology brain, Neuroradiology spine, MR, Imaging sequences, Cerebrospinal fluid, Inflammation
References

References

 

  1. Mohan S, Jain KK, Arabi M, Shah GV. Imaging of meningitis and ventriculitis. Neuroimaging Clinics of North America. 2012;22(4):557-83.
  2. Duong MT. Neuroimaging Patterns of Intracranial Infections. Central Nervous System Infections, An Issue of Neuroimaging Clinics of North America. 2022;33(1):11.
  3. Hughes D, Raghavan A, Mordekar S, Griffiths P, Connolly D. Role of imaging in the diagnosis of acute bacterial meningitis and its complications. Postgraduate medical journal. 2010;86(1018):478-85.
  4. Duarte SBL, Oshima MM, Mesquita JVdA, Nascimento FBPd, Azevedo PCd, Reis F. Magnetic resonance imaging findings in central nervous system cryptococcosis: comparison between immunocompetent and immunocompromised patients. Radiologia brasileira. 2017;50:359-65.
  5. Sanei Taheri M, Karimi MA, Haghighatkhah H, Pourghorban R, Samadian M, Delavar Kasmaei H. Central nervous system tuberculosis: an imaging‐focused review of a reemerging disease. Radiology Research and Practice. 2015;2015(1):202806.
  6. Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM. Neurosarcoidosis: pathophysiology, diagnosis, and treatment. Neurology: Neuroimmunology & Neuroinflammation. 2021;8(6):e1084.
  7. Kurokawa R, Kurokawa M, Isshiki S, Harada T, Nakaya M, Baba A, et al. Dural and leptomeningeal diseases: anatomy, causes, and neuroimaging findings. RadioGraphics. 2023;43(9):e230039.
  8. Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84(11):1165-73.
  9. Villa E, Sarquis T, de Grazia J, Núñez R, Alarcón P, Villegas R, et al. Rheumatoid meningitis: a systematic review and meta‐analysis. European Journal of Neurology. 2021;28(9):3201-10.
  10. Jones SE, Belsley NA, McLoud TC, Mullins ME. Radiologic-Pathologic Conference of the Massachusetts General Hospital: Rheumatoid Meningitis: Radiologic and Pathologic Correlation. American Journal of Roentgenology. 2006;186(4):1181-3.
  11. Theodorou A, Palaiodimou L, Safouris A, Kargiotis O, Psychogios K, Kotsali-Peteinelli V, et al. Cerebral Amyloid Angiopathy—Related Inflammation: A Single-Center Experience and a Literature Review. Journal of Clinical Medicine. 2022;11(22):6731.
  12. Beckius S, Shah K. Intracranial and systemic manifestations of familial leptomeningeal amyloidosis, as seen on CT and MRI. Radiology Case Reports. 2018;13(6):1179-84.
  13. Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, et al. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta neuropathologica. 2012;124:627-41.
  14. Pirini M-G, Mascalchi M, Salvi F, Tassinari CA, Zanella L, Bacchini P, et al. Primary diffuse meningeal melanomatosis: radiologic-pathologic correlation. American journal of neuroradiology. 2003;24(1):115-8.
  15. Birzu C, Tran S, Bielle F, Touat M, Mokhtari K, Younan N, et al. Leptomeningeal spread in glioblastoma: diagnostic and therapeutic challenges. The Oncologist. 2020;25(11):e1763-e76.
  16. Bartlett F, Kortmann R, Saran F. Medulloblastoma. Clinical oncology. 2013;25(1):36-45.
  17. Mehta RI, Cutler AR, Lasky III JL, Yong WH, Lerner JT, Hirota BK, et al. “Primary” leptomeningeal medulloblastoma. Human pathology. 2009;40(11):1661-5.
  18. Komotar RJ, Burger PC, Carson BS, Brem H, Olivi A, Goldthwaite PT, et al. Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery. 2004;54(1):72-80.
  19. Taylor JW, Flanagan EP, O'Neill BP, Siegal T, Omuro A, DeAngelis L, et al. Primary leptomeningeal lymphoma: international primary CNS lymphoma collaborative group report. Neurology. 2013;81(19):1690-6.
  20. Ginsberg L. Contrast enhancement in meningeal and extra-axial disease. Neuroimaging Clinics of North America. 1994;4(1):133-52.
  21. Pereira S, Vieira B, Maio T, Moreira J, Sampaio F. Susac’s syndrome: an updated review. Neuro-Ophthalmology. 2020;44(6):355-60.
  22. Komiyama M, Nakajima H, Nishikawa M, Yasui T, Kitano S, Sakamoto H. Leptomeningeal contrast enhancement in moyamoya: its potential role in postoperative assessment of circulation through the bypass. Neuroradiology. 2001;43:17-23.
  23. McKinney AM, Kieffer SA, Paylor RT, SantaCruz KS, Kendi A, Lucato L. Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. American Journal of Roentgenology. 2009;193(1):192-206.
  24. Bernard KR, Rivera M. Reversible cerebral vasoconstriction syndrome. The Journal of Emergency Medicine. 2015;49(1):26-31.
  25. Choi HY, Lee KM, Kim H-G, Kim EJ, Choi WS, Kim BJ, et al. Role of hyperintense acute reperfusion marker for classifying the stroke etiology. Frontiers in Neurology. 2017;8:630.
  26. Park MS, Suh DC, Choi WS, Lee SY, Kang GH. Multifocal meningioangiomatosis: a report of two cases. American journal of neuroradiology. 1999;20(4):677-80.
  27. Griffiths P. Sturge-Weber syndrome revisited: the role of neuroradiology. Neuropediatrics. 1996;27(06):284-94.

 
GALLERY